Trial Profile
Phase Ib Trial of Encapsulated Rapamycin (eRapa) in Prostate Cancer Patients Under Active Surveillance
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 04 Nov 2021
Price :
$35
*
At a glance
- Drugs Sirolimus (Primary)
- Indications Prostate cancer
- Focus Adverse reactions; First in man
- 30 Mar 2020 Status changed from active, no longer recruiting to completed.
- 04 Feb 2020 Results presented in the Emtora Biosciences media release.
- 04 Feb 2020 According to an Emtora Biosciences media release, data from this trial will be presented at the in a poster presentation (Abstract Number: 34) at the American Society of Clinical Oncology (ASCO) and Society for Immunotherapy of Cancer (SITC) Clinical Immuno-Oncology Symposium to be held in Orlando, FL, February 6-8.